Page last updated: 2024-08-23

4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and Focal Segmental Glomerulosclerosis

4,4'-diisothiocyanostilbene-2,2'-disulfonic acid has been researched along with Focal Segmental Glomerulosclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aviram, S; Cheng, K; Jhaveri, A; Lan, X; Malhotra, A; Mathieson, PW; Mikulak, J; Saleem, MA; Singhal, PC; Skorecki, K; Wen, H1

Other Studies

1 other study(ies) available for 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and Focal Segmental Glomerulosclerosis

ArticleYear
APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.
    American journal of physiology. Renal physiology, 2014, Aug-01, Volume: 307, Issue:3

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Actins; Apolipoprotein L1; Apolipoproteins; Black or African American; Cells, Cultured; Chloride Channels; Chloroquine; Genetic Predisposition to Disease; Genetic Variation; Glomerulosclerosis, Focal Segmental; Humans; Lipoproteins, HDL; Lysosomes; Necrosis; Permeability; Podocytes

2014